OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2
Anjani, Sumit Kumar, Brijesh Rathi, et al.
RSC Advances (2023) Vol. 13, Iss. 6, pp. 3677-3687
Open Access | Times Cited: 8

Showing 8 citing articles:

Structure-Based Discovery of the SARS-CoV-2 Main Protease Noncovalent Inhibitors from Traditional Chinese Medicine
Xiaojie Jin, Min Zhang, Beibei Fu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 4, pp. 1319-1330
Closed Access | Times Cited: 7

Unlocking the Antiviral Arsenal: Structure-Guided Optimization of Small-Molecule Inhibitors against RSV and hCoV-229E
Christina Karhan, Svenja M. Sake, Antonia P. Gunesch, et al.
European Journal of Medicinal Chemistry (2025), pp. 117282-117282
Open Access

Therapeutic potential of ASK1 activators in cancer treatment: Current insights and future directions
Bo Wang, Ying Ma, Yue Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117214-117214
Closed Access | Times Cited: 5

Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2
Bobban Subhadra, Ragini Agrawal, Virender Kumar Pal, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1299-1299
Open Access | Times Cited: 4

Identification of potential antiviral lead inhibitors against SARS-CoV-2 main protease: Structure-guided virtual screening, docking, ADME, and MD Simulation based approach
Goverdhan Lanka, Revanth Bathula, Balaram Ghosh, et al.
Artificial Intelligence Chemistry (2023) Vol. 1, Iss. 2, pp. 100015-100015
Open Access | Times Cited: 3

Screening, Synthesis and Biochemical Characterization of SARS-CoV-2 Protease Inhibitors
Martynas Bagdonas, Kamilė Čerepenkaitė, Aurelija Mickevičiūtė, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13491-13491
Open Access | Times Cited: 2

Inhibition of SARS-CoV-2 3CLpro by chemically modified tyrosinase from Agaricus bisporus
David Aguilera-Rodriguez, David Ortega-Alarcón, Ángela Vázquez-Calvo, et al.
RSC Medicinal Chemistry (2024)
Open Access

Page 1

Scroll to top